MOESM2 of Enrichment of superoxide dismutase 2 in glioblastoma confers to acquisition of temozolomide resistance that is associated with tumor-initiating cell subsets

  • Pin Yuan Chen (Contributor)
  • Wen-Bin Yang (Creator)
  • Shao Wen Chou (Creator)
  • Shun Tai Yang (Creator)
  • Pei Hsuan Chung (Contributor)
  • Kwang Yu Chang (Contributor)
  • Ming Sheng Liu (Creator)
  • Shang Hung Chen (Contributor)
  • Chia Hung Chien (Contributor)
  • Tsung-I Hsu (Contributor)
  • Jui Mei Chu (Contributor)
  • Chih Yuan Huang (Contributor)
  • Ka Yen Yang (Creator)
  • Jr Jiun Liu (Creator)
  • Jian-Ying Chuang (Creator)
  • Wei-Lun Lo (Creator)



Additional file 2: Figure S2. Kaplan-Meier curves of an array database from SurvExpress ( ) [18]. The original data included samples of (A) GBM from Joo KM, et al., 2013 ( ), (B) low-grade glioma and GBM from Phillips HS, et al., 2006 ( ), and (C) low-grade glioma and GBM from TCGA. Each line refers to cases in which SOD2 gene expression was higher or lower than the median.
Date made available2019

Cite this